“PGx reporting software” covers a surprisingly wide range of tools — from single-purpose interpretation engines to full lab platforms. This guide breaks down what the term really means, the capabilities that matter, and the categories of products available, so you can match a tool to how your PGx lab actually works.
The short version
- PGx reporting tools fall into four buckets: interpretation/point tools, genomics LIMS, clinical LIS, and integrated LIS/LIMS platforms.
- The right fit depends on whether you need just report generation, or the whole workflow from order to report to claim.
- Key criteria: evidence sourcing (CPIC/FDA/PharmGKB), branded templates, lab review/approval, delivery, integrations, billing, and security.
- Disclosure: we build Labrynix, an integrated LIS/LIMS + PGx reporting platform — we've tried to keep this guide useful regardless of what you choose.
What “PGx reporting software” actually means
Some teams mean a tool that takes a genotype and produces interpreted report content. Others mean the entire system that runs the lab — orders, samples, reporting, delivery, and billing. Both are valid; they're just different scopes. Before comparing products, decide whether you need a report generator that plugs into your existing systems, or a platform that runs the workflow end to end.
The capabilities that matter
Whatever the scope, strong PGx reporting software should offer:
- Evidence-informed content — the ability to reference CPIC guidelines, FDA pharmacogenomic labeling, and PharmGKB annotations, applied through your lab's own validated rules.
- Consistent genotype-to-phenotype logic — diplotype and metabolizer-status translation that's standardized and traceable.
- Branded, customizable templates — reports that look like your lab's and read clearly for providers (and sometimes patients).
- Review and approval workflow — sign-off by qualified staff before anything is released.
- Secure delivery — controlled portal delivery, not unmanaged PDFs over email.
- AI assistance under control — drafting and summarization that speeds review without replacing it.
- Interoperability — HL7/FHIR-ready exchange with EMR/EHR and instruments.
- Compliance — HIPAA, and ideally SOC 2 / ISO 27001-backed security for sensitive genetic data.
The four categories of tools
1. Interpretation / point tools
Dedicated variant-analysis and interpretation suites are strong at the science — variant calling, annotation, and report content. They're a good fit if you already have a LIS/LIMS and just need a focused interpretation/reporting layer. The trade-off: they usually don't run orders, samples, delivery, or billing, so you'll integrate them into a broader stack.
2. Genomics / NGS LIMS
LIMS platforms from sequencing and informatics vendors excel at sample-centric, high-throughput workflows. If your bottleneck is library prep, runs, and batch tracking, they're compelling. The gap for PGx labs is usually the patient-centric side: clinical reporting, provider/patient portals, and especially billing/RCM are typically not included.
3. Clinical LIS
Traditional clinical and pathology LIS platforms handle patients, orders, results, reporting, and often billing well. Many, however, were built for anatomic pathology or general clinical chemistry — their genetics, variant, and PGx-specific workflows can be shallow or bolt-on.
4. Integrated LIS/LIMS + reporting platforms
These aim to do both sides — sample-centric LIMS workflows and patient-centric LIS reporting, billing, and portals — in one system. For a PGx lab that wants order-to-report-to-claim on one record, this is the most complete fit. The thing to verify is genetics depth: does the platform actually understand PGx reporting, or is it a general LIS with a genetics label?
How to evaluate vendors
Useful questions to ask any PGx reporting vendor:
- How do you support CPIC, FDA, and PharmGKB content — and who controls the interpretation rules?
- Can reports be fully branded and customized to our templates?
- What does the review and approval workflow look like before a report is released?
- How are reports delivered to providers and patients?
- What integrations (HL7/FHIR, EMR/EHR, instruments) are supported, and at what scope?
- Is billing/RCM included, or separate?
- What security and compliance posture do you hold (HIPAA, SOC 2, ISO 27001, BAAs)?
- How is AI used — and does it ever bypass lab review? (It shouldn't.)
Where Labrynix fits
For transparency: Labrynix is in the fourth category — an integrated LIS/LIMS hybrid with PGx reporting built in. It runs orders and samples, generates branded, evidence-informed PGx reports with AI-assisted drafting under lab review, delivers through provider and patient portals, connects systems via HL7/FHIR, and tracks billing— purpose-built for genetic, molecular, and PGx labs. Whether or not that's your pick, use the criteria above to compare honestly.
Frequently asked questions
Do I need dedicated PGx software or just a LIMS?
A general LIMS handles samples but usually not clinical PGx reporting, delivery, or billing. If your output is patient-facing PGx reports, you need software that does the reporting and patient-centric side — either a dedicated reporting tool plus your LIMS, or an integrated platform.
Should AI write PGx reports?
AI can draft and summarize to speed review, but the lab must validate, review, and approve every report. Look for AI that assists qualified review rather than replacing it.